Clinical trial

Pharmacokinetics of Rivaroxaban After Bariatric Surgery

NCT04180436

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-01-15

PhasePHASE1

Study timeline

Study start (actual)2020-01-15Date precision: day

Registry last updated2025-12-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Bariatric Surgeryunresolved

Morbid Obesityunresolved

Interventions

rivaroxaban 20 mg once daily 8 daysDRUG

Sponsors & collaborators

University Hospital, Brestlead sponsor

Bayercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04180436 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.